Monolayer Oral Solid Dose Dispense Bottles and Closure Shells

Extrusion blow moulding of monolayer oral solid dose dispense bottles with DPDB-3135 NT7 is run at a base resin addition of 100 wt% neat when the immediate contact layer must satisfy USP <661.1>, Ph. Eur. 3.1.3, and FDA 21 CFR 177.1520(c) without the migration risk associated with off-specification masterbatch carriers. The resin is processed as a medium-density polyethylene with a nominal density of 0.935 g/cm³ per ISO 1183-1:2022 and a melt mass-flow rate of 0.35 g/10 min at 190 °C/2.16 kg per ISO 1133-1:2022. In-line regrind from tail trim, start-up purges, and rejected parisons is limited to 20 wt% of total feed by mass; regrind is pre-dried at 70–80 °C for 2–3 h when storage relative humidity has exceeded 60%, because surface moisture on flake can generate micro-void striations at the pinch-off weld. A pharmaceutical-grade polyethylene colour masterbatch is added only when required, at ≤2.0 wt%, and the masterbatch carrier accounts for a proportional reduction in neat resin to keep total olefin polymer at 100 wt%. Processing is performed on shuttle or long-stroke reciprocating blow moulders fitted with 24:1 L/D to 25:1 L/D barrier screws and grooved feed sections. Cylinder temperatures are set in the range 175–205 °C, melt temperature at the die is maintained at 185–210 °C, mould temperature is held at 10–20 °C, die gap is 0.8–2.5 mm, and blow air pressure is controlled at 0.6–0.8 MPa. The blow ratio is kept between 2:1 and 3:1; when the blow ratio exceeds 3.2:1, sidewall thinning in the bottle lower third becomes non-uniform, a failure mode observed on production-scale shuttle lines as inconsistent drop-impact performance under ASTM D2463-15. Terminal product types include pharmacist dispense bottles, tamper-evident closure shells, and oral solid dose containers from 20 mL to 250 mL, with wall thicknesses of 0.5–1.5 mm.

When cleanroom sheet extrusion is specified for medical device sterile barrier trays, the contact layer is run at 100 wt% virgin DPDB-3135 NT7, while edge-trim regrind is limited to 15 wt% because higher regrind fractions increase gel counts that can compromise tray flange sealing under ethylene oxide or gamma sterilisation at 25–50 kGy. The governing compliance set includes ISO 11607-1:2019 for sterile barrier systems, EN 868-2 where the notified-body technical file requires harmonised packaging test evidence, ISO 10993-5:2009 for cytotoxicity, and FDA 21 CFR 177.1520(c) for the olefin polymer contact layer. The production route is flat-die extrusion on a single-screw extruder with 30:1 L/D, screen pack filtration at 40/60/120 mesh to reduce gel transfer, die temperature from 190 °C to 215 °C, and a polished three-roll stack maintained at 60–80 °C to set sheet crystallinity and residual stress. Extruded sheet thickness is typically 0.30–1.20 mm. Thermoforming follows in-line or offline at a sheet surface temperature of 155–175 °C; the forming depth is restricted to 0.75 times the aperture to avoid corner thinning beyond 20% of nominal sheet thickness, which is the main thermoforming boundary identified on industrial lines. Because DPDB-3135 NT7 has lower modulus than amorphous PETG, tray ribs and denesting lugs require deeper draw geometry or ribbed sidewalls to achieve equivalent panel stiffness. Terminal products are single-use device trays, pre-loaded surgical procedure kits, and rigid outer trays for double-pouch sterile barriers.

What limits regrind retention in diagnostic reagent containers produced on accumulator-head blow moulders?

The governing constraint in diagnostic reagent container production on accumulator-head blow moulders is not melt stability but retention of low extractables after multiple heat histories, which is why the base resin addition is 75–100 wt% with same-family regrind capped at 25 wt% for buffer bottles and 10 wt% for calibration solution containers. The accumulator-head machine is configured with a 20:1 L/D to 24:1 L/D extruder, programmed parison control, and 8–15 °C mould cooling to set neck-finish dimensions without silicone-based mould release, because silicone migration into reagent-grade aqueous matrices is a documented interference source in enzyme immunoassays. Melt temperature is controlled at 185–205 °C; operation above 210 °C increases low-molecular-weight fractions that can mobilise during accelerated extractables testing. The process uses a pin-and-bushing die set rather than a hot-runner manifold, and the die temperature is held 5–10 °C below the melt temperature to raise melt strength at the parison. Compliance documentation references IVDR (EU) 2017/746, ISO 13485:2016, FDA 21 CFR 820, USP <661.2>, Ph. Eur. 3.1.3, and USP <1663> for extractables assessment. Published quantitative migration data for this specific resin in diagnostic reagent matrices is limited, so lot qualification is performed by extraction ratio testing rather than by assuming equivalence with legacy HDPE grades. Terminal container types are 5 mL to 1 L reagent bottles, lyophilized control vials, calibration buffer bottles, and screw-neck bottles for in-vitro diagnostic analyser consumables.

At 2.5 wt% carbon black masterbatch loading for UV-stable laboratory buffer bottles, the DPDB-3135 NT7 fraction is reduced to 97.5 wt%, and the masterbatch carrier is selected from a narrow-molecular-weight polyethylene that does not alter the melt flow ratio of the neat resin by more than 10%; otherwise the parison curvature changes and reject rates rise on multi-cavity shuttle lines. The masterbatch is pre-dried to 0.015 wt% moisture and the feed-throat temperature is kept below 50 °C to prevent bridging in the hopper. Continuous shuttle blow moulding with in-line leak detection is run at a melt temperature of 190–210 °C, a mould temperature of 10–16 °C, and a parison drop time reduced by 8–12% compared with neat resin to compensate for the higher extensional viscosity imparted by the carbon black structure. The die gap is increased by 0.05–0.15 mm relative to the unpigmented setting to maintain the same wall thickness distribution. Compliance for the finished bottle system references ASTM D1693-15 condition B for environmental stress crack resistance, ASTM D256 for notched Izod impact, ASTM D638-14 for tensile yield, ISO 1183-1 for density, USP <661.1> for physicochemical suitability, and REACH (EC) No 1907/2006 for registration. Terminal products are black or dark-tinted laboratory wash bottles, light-sensitive reagent storage containers, and buffer reservoirs up to 2 L.

For surfactant-based personal care containers, stress crack resistance rather than burst strength defines shelf life

Containers for surfactant-based personal care formulations exercise the environmental stress crack resistance of DPDB-3135 NT7 under continuous contact with non-ionic and anionic surfactant solutions, so the base resin addition is kept at 100 wt% in the wall layer and colour masterbatch is limited to 1.5 wt% when brand opacity is required. The conversion route is extrusion blow moulding on dual-station shuttle machines with 24:1 L/D extruders, mould temperatures of 12–18 °C, and melt temperatures not exceeding 200 °C for alcohol-containing fill formulations; lower melt temperature preserves the high-molecular-weight fraction that controls slow crack growth. Pinch-off weld strength is evaluated by ASTM D2463-15 drop impact on filled bottles rather than by burst strength alone, because weld-region micro-voids formed under high shear are not always detected by hydraulic burst tests. The container article is qualified under ASTM D1693-15 condition B or C, ASTM D638-14 for tensile properties, ISO 11607-1 where the container is used as a primary package for medical cosmetic devices, FDA 21 CFR 177.1520(c) for food-adjacent cosmetic packaging, and EC No 1223/2009 for cosmetic product packaging conformity. Terminal products include cylindrical pump bottles, oval squeeze containers, and flip-cap tubes in the 50 mL to 500 mL capacity range.